Durvalumab versus placebo with chemoradiotherapy for locally advanced cervical cancer (CALLA): a randomised, double-blind, phase 3 trial-Reference-Cited by-同舟云学术

Durvalumab versus placebo with chemoradiotherapy for locally advanced cervical cancer (CALLA): a randomised, double-blind, phase 3 trial

Published:2023-12 Issue:12 Volume:24 Page:1334-1348
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Monk Bradley J,Toita Takafumi,Wu Xiaohua,Vázquez Limón Juan C,Tarnawski Rafal,Mandai Masaki,Shapira-Frommer Ronnie,Mahantshetty Umesh,del Pilar Estevez-Diz Maria,Zhou Qi,Limaye Sewanti,Godinez Francisco J Ramirez,Oppermann Kussler Christina,Varga Szilvia,Valdiviezo Natalia,Aoki Daisuke,Leiva Manuel,Lee Jung-Yun,Sulay Raymond,Kreynina Yulia,Cheng Wen-Fang,Rey Felipe,Rong Yi,Ke Guihao,Wildsmith Sophie,Lloyd Andrew,Dry Hannah,Tablante Nunes Ana,Mayadev Jyoti

Funder

AstraZeneca

Publisher

Elsevier BV

Subject

Oncology

Reference32 articles.

1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J Clin,2021

2. New standard of care for cervical cancer sets stage for next questions;McNeil;J Natl Cancer Inst,1999

3. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer;Rose;N Engl J Med,1999

4. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study;Whitney;J Clin Oncol,1999

5. MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study;Pötter;Lancet Oncol,2021

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of immune, inflammatory and nutritional indices on outcome in patients with locally advanced cervical cancer treated with definitive (chemo)radiotherapy;Gynecologic Oncology;2024-11

2. Pharmacokinetics and pharmacodynamics of angiogenesis inhibitors used to treat cervical cancer: current and future;Expert Opinion on Drug Metabolism & Toxicology;2024-09-09

3. Pembrolizumab plus Radiochemotherapie bei lokal fortgeschrittenem Zervixkarzinom – die prospektive, randomisierte KEYNOTE-A18-Phase-3-Studie;Strahlentherapie und Onkologie;2024-09-04

4. Cervical cancer: Part II the landscape of treatment for persistent, recurrent and metastatic diseases (I);Taiwanese Journal of Obstetrics and Gynecology;2024-09

5. Surgery-based radiation-free multimodality treatment for locally advanced cervical cancer;Taiwanese Journal of Obstetrics and Gynecology;2024-09